PubMed Disclaimer Editor In ChiefMichael Rosenblum PhD Professor
journal of nanotechnology June 12th, 2008Editors Advertisements please visit our sponsors page. Disclaimer Editor In ChiefMichael Rosenblum, PhD Professor of MedicineChief of the Immunopharmacology & Targeted Therapy SectionDepartment of BioimmunotherapyThe University of Texas MD Anderson Cancer CenterConsultant, CSixty, Nanotechnology CompanyHouston, Texas, USA Associate EditorWade Adams, PhD DirectorCenter for Nanoscale Science and TechnologyRice UniversityHouston, Texas, USA This is peer reviewed journal. Current Issue VITAGEN Announces Enrollment For Phase II Trial Of ELAD BioartificialLiver Support Therapy Home Sponsors Instructions for Authors Archives Journals PubMed All articles are archived by Internet Scientific Publications LLC and recognized by The Library of Congress Catalog of Publications.
Advertisement The Internet Journal of Nanotechnology TM 19378262 Home Sponsors Every published article has been reviewed by members of the editorial board and the editorinchief. Contact Copyright Internet Scientific Publications, LLC, to Journals Medical Books Disclaimer Editor In ChiefMichael Rosenblum, PhD Professor of MedicineChief of the Immunopharmacology & Targeted Therapy SectionDepartment of BioimmunotherapyThe University of Texas MD Anderson Cancer CenterConsultant, CSixty, Nanotechnology CompanyHouston, Texas, USA Associate EditorWade Adams, PhD DirectorCenter for Nanoscale Science and TechnologyRice UniversityHouston, Texas, USA This is peer reviewed journal. All articles are archived by Internet Scientific Publications LLC and recognized by The Library of Congress Catalog of Publications.